Gene · 5696
Papers2,476
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
261 to 280 of 2,476
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Genomic and transcriptomic analysis of checkpoint blockade response in advanced non-small cell lung cancer. | Nat Genet | 2023 | 37024582 | PubTator, text mining | PubMed |
| An Analysis Regarding the Association Between Proteasome (PSM) and Hepatocellular Carcinoma (HCC). | J Hepatocell Carcinoma | 2023 | 37020465 | PubTator, text mining | PubMed |
| Effects of prenatal pesticide exposure on the fetal brain and placenta transcriptomes in a rodent model. | Toxicology | 2023 | 37019170 | PubTator, text mining | PubMed |
| Integrated host/microbe metagenomics enables accurate lower respiratory tract infection diagnosis in critically ill children. | J Clin Invest | 2023 | 37009900 | PubTator, text mining | PubMed |
| Immune responses of different COVID-19 vaccination strategies by analyzing single-cell RNA sequencing data from multiple tissues using machine learning methods. | Front Genet | 2023 | 37007947 | PubTator, text mining | PubMed |
| Comprehensive Explorations of CCL28 in Lung Adenocarcinoma Immunotherapy and Experimental Validation. | J Inflamm Res | 2023 | 37006812 | PubTator, text mining | PubMed |
| A chemokine network of T cell exhaustion and metabolic reprogramming in renal cell carcinoma. | Front Immunol | 2023 | 37006314 | PubTator, text mining | PubMed |
| Single cell RNA-seq resolution revealed CCR1+/SELL+/XAF+ CD14 monocytes mediated vascular endothelial cell injuries in Kawasaki disease and COVID-19. | Biochim Biophys Acta Mol Basis Dis | 2023 | 37001702 | PubTator, text mining | PubMed |
| An immune indicator based on BTK and DPEP2 identifies hot and cold tumors and clinical treatment outcomes in lung adenocarcinoma. | Sci Rep | 2023 | 36991102 | PubTator, text mining | PubMed |
| Metabolic Alterations in Multiple Myeloma: From Oncogenesis to Proteasome Inhibitor Resistance. | Cancers (Basel) | 2023 | 36980568 | PubTator, text mining | PubMed |
| Establishing 20S Proteasome Genetic, Translational and Post-Translational Status from Precious Biological and Patient Samples with Top-Down MS. | Cells | 2023 | 36980185 | PubTator, text mining | PubMed |
| FAK suppresses antigen processing and presentation to promote immune evasion in pancreatic cancer. | Gut | 2023 | 36977556 | PubTator, text mining | PubMed |
| Design and Computational Analysis of an MMP9 Inhibitor in Hypoxia-Induced Glioblastoma Multiforme. | ACS Omega | 2023 | 36969457 | PubTator, text mining | PubMed |
| Case report: De novo SAMD9L truncation causes neonatal-onset autoinflammatory syndrome which was successfully treated with hematopoietic stem cell transplantation. | Front Pediatr | 2023 | 36969289 | PubTator, text mining | PubMed |
| Zetomipzomib (KZR-616) attenuates lupus in mice via modulation of innate and adaptive immune responses. | Front Immunol | 2023 | 36969170 | PubTator, text mining | PubMed |
| DNA hypomethylation mediates immune response in pan-cancer. | Epigenetics | 2023 | 36945884 | PubTator, text mining | PubMed |
| Sequence Variants in PSMB8/PSMB9 Immunoproteasome Genes and Risk of Urothelial Bladder Carcinoma. | Cureus | 2023 | 36937130 | PubTator, text mining | PubMed |
| Systematic integration of machine learning algorithms to develop immune escape-related signatures to improve clinical outcomes in lung adenocarcinoma patients. | Front Immunol | 2023 | 36936970 | PubTator, text mining | PubMed |
| Optimization of CRISPR-Cas system for clinical cancer therapy. | Bioeng Transl Med | 2023 | 36925702 | PubTator, text mining | PubMed |
| The mitochondrial pyruvate carrier complex potentiates the efficacy of proteasome inhibitors in multiple myeloma. | Blood Adv | 2023 | 36920785 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/5696/papers?page=14